- Events
22/08/2025
From September 8 to 12, 2025, we will be attending the International HBV Meeting in Berlin – a major scientific event dedicated to advancing hepatitis B virus research.
Our Business Developer, Ha-Yeon Kim-Penard, PhD, will be on-site to connect with researchers, biotech companies, and pharmaceutical partners working on innovative antiviral strategies.
With our humanized mouse models – including our hu-liver model – we support R&D teams in assessing the efficacy, toxicity, and pharmacokinetics of new drug candidates targeting HBV.